Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Instrumentation Grant Program for Resource-Limited Institutions

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Instrumentation Grant Program for Resource-Limited Institutions, offered by the National Institutes of Health under the Department of Health and Human Services, aims to support institutions with limited NIH Research Project Grant funding by facilitating the acquisition of modern scientific instruments. This initiative is designed to enhance the biomedical research capacity and educational opportunities at these resource-limited institutions, enabling them to advance their scientific capabilities. The program is forecasted to be posted on August 27, 2025, and serves as an important opportunity for eligible institutions to upgrade their research infrastructure. Interested parties can contact Dr. Dorothy Beckett for more information or clarification regarding the program. The grant emphasizes the enhancement of research tools to foster scientific growth and improve educational outcomes in biomedical fields.

General Info

NIH grant supports resource-limited institutions upgrading scientific instruments to enhance biomedical research.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

923120 - Administration of Public Health Programs

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedAug 27

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health

Office AddressUSA

Contacts

Dorothy Beckett Ph.D

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

The NIH Instrumentation Grant Program for Resource-Limited Institutions (RLI) supports the purchase of modern scientific instruments to enhance biomedical research capacity and education at institutions with limited NIH Research Project Grant funding.

Similar Contracts

Same NAICS industry code

27EHSCARHTPRURALPARTNERSRFA: Rural Health Transformation Program (RHTP) Rural Partners RFA

Solicitation # BD-27-1039-EHS01-EHS01-134186

The Massachusetts Executive Office of Health and Human Services (EOHHS) is implementing the Rural Health Transformation Program (RHTP), a five-year, 800 million dollar federal investment funded by the Centers for Medicare & Medicaid Services (CMS). This initiative aims to strengthen healthcare access, improve population health, and advance long-term well-being across rural Massachusetts. The program provides technical assistance, planning support, and direct funding across six key initiatives: Population Health Advancement, Innovation in Rural Care Models, Healthcare Training (THRIVE), Healthy Rural Communities, Technology Interoperability and Connectivity, and Facility Modernization and Re-Use. Eligible rural facilities, providers, municipalities, and community organizations must submit their applications by October 26, 2026, at 5:00 PM ET. Funding is distributed based on specific activity limits, ranging from capital updates for rural hospitals up to 2.5 million dollars per facility to smaller implementation awards of up to 100,000 dollars. The initial period of participation runs from October 30, 2026, through September 30, 2027, with future participation not guaranteed. Award decisions are based on the scope of applications, available funding, program priorities, and demonstrated community need. All grantees are considered sub-recipients of federal funds and must comply with OMB Circular A-133 audit requirements.

POSTED

DEADLINE

Public Health Strategy & Collective Impact ConsultingThis subcontract for Public Health Strategy and Collective Impact Consulting supports the Guilford County Department of Health and Human Services in North Carolina. The primary objective is to provide strategic planning and capacity building for prime contractors, specifically focusing on the implementation of a multi-year collective action framework designed to reduce infant mortality. By utilizing Collective Impact models, the project aims to enhance organizational performance and strengthen the capabilities of public health officials. The selected provider will be responsible for delivering a comprehensive implementation roadmap, detailed capacity building reports, and defined strategic performance milestones. This effort falls under NAICS code 923120 and is managed by the County of Guilford. Interested parties must respond by October 30, 2026.

County of Guilford

POSTED

DEADLINE

Accelerated Implementation of Data Management and Sharing Plan Changes for NIH Career Development (K) Awards

Solicitation # NOT-OD-26-120

The National Institutes of Health has issued notice NOT-OD-26-120 to accelerate the removal of Data Management and Sharing Plan requirements for Career Development (K) Awards. While previously scheduled for October 12, 2027, this change is now effective immediately. The decision stems from the fact that K awards prioritize career development over primary research project support, and removing this requirement is intended to reduce the administrative burden on both applicants and their institutions. Under these updated guidelines, active K award recipients are no longer required to submit or update a DMS Plan, including within the Research Performance Progress Report. This exemption also applies to pending applications currently in the pre-award or Just-in-Time process, as well as all future applications. The NIH has clarified that the absence of a DMS Plan for these specific awards will not be viewed as noncompliant with general data sharing policies.

National Institutes Of Health Office Of The Director

POSTED

DEADLINE

NIH Operates Under a Continuing Resolution

Solicitation # NOT-OD-26-131

The National Institutes of Health is operating under the Continuing Appropriations and Extensions Act, 2027, which extends government operations through December 11, 2026, at the Fiscal Year 2026 enacted level. Under this resolution, the NIH is prohibited from implementing revisions to the Uniform Administrative Requirements for Federal Awards until the expiration date. Additionally, NIH Institutes and Centers maintain the discretion to issue non-competing research grant awards at levels lower than those listed on the most recent Notice of Award, with potential upward adjustments considered only after FY 2027 appropriations are enacted. All legislative mandates and fiscal policies from FY 2026 remain in effect, including the salary limitation set at Executive Level II of the Federal Pay Scale. The Ruth L. Kirschstein National Research Service Award stipend levels and tuition fees also remain consistent with previous notices. Institutions are expected to monitor their expenditures closely during this period to ensure financial stability until new appropriations are finalized.

National Institutes Of Health

POSTED

DEADLINE

Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.The Centers for Disease Control and Prevention is offering funding to a single recipient to enhance collaboration and relationships between tuberculosis control programs, TB controllers, and various affiliated partners across the United States. This initiative builds upon previous efforts to strengthen ties with national TB control programs, federal agencies, academic institutions, businesses, and community or faith-based organizations. The primary goal of this effort is to support the CDC Division of Tuberculosis Elimination in its mission to prevent, control, and eventually eliminate tuberculosis to improve overall health and quality of life. This forecast is managed by the Department of Health and Human Services under the National Center for HIV, Viral Hepatitis, Hepatitis B, and STI, with Martha Boisseau serving as the point of contact.

Centers For Disease Control - Nchhstp

POSTED

DEADLINE

Notice of Opportunity to Participate in the Implementation Council for One Care

Solicitation # BD-27-1039-EHS01-ASHWA-133664

The Massachusetts Executive Office of Health and Human Services, through MassHealth, is seeking diverse individuals and representatives from community-based organizations to serve on the Implementation Council for the One Care program. One Care is a coordinated health plan that integrates Medicare and MassHealth benefits for eligible adults aged 21 to 64. The Council's primary purpose is to partner with MassHealth to improve program delivery by monitoring healthcare access, reviewing member experiences, and advising on strategies to strengthen services related to mental health, substance use, and long-term supports. Selected members will serve an initial two-year term with the possibility of an extension. The commitment involves attending virtual meetings via Zoom twice per month during regular business hours, with each session lasting approximately two hours. Compensation is provided via stipends, including 75 dollars per Implementation Council meeting attended and 25 dollars per hour for approved engagement meetings or activities, such as in-person town halls. Applicants must submit a completed application form by November 2, 2026, at 5:00 PM. Evaluations are conducted by a committee based on the clarity and completeness of the application, the applicant's understanding of the Council's goals, and their relevant knowledge and experience with One Care. To avoid conflicts of interest, individuals with direct or indirect employment or contractual relationships with My Ombudsman or a One Care Plan are generally ineligible to serve. All submitted applications are subject to the Massachusetts Public Records Law.

POSTED

DEADLINE

Advancing Global Health

Solicitation # DFOP0017890

The Department of State Bureau of Global Health Security and Diplomacy is soliciting Statements of Interest under the Advancing Global Health Annual Program Statement (DFOP0017890) to implement the America First Global Health Strategy. This initiative seeks to save lives, strengthen health systems, and foster self-reliance through a supplemental framework that complements bilateral Memoranda of Understanding (MOUs) with partner governments. The program anticipates up to 100 awards with individual values ranging from $500,000 to $250 million, with total estimated funding available up to $4.5 billion over performance periods of up to five years. Funding is distributed through specific Addenda targeting diverse global health priorities. These include large-scale health system transitions and MOU implementations in Nigeria, Mozambique, Uganda, Malawi, and Cote d'Ivoire, as well as thematic initiatives such as the elimination of neglected tropical diseases, accelerating nutrition progress, rapid outbreak response, child protection, and innovations in population-based surveillance. The application process is a two-step competition beginning with a Statement of Interest, which is evaluated based on the quality of the program idea, organizational capacity, and the ability to achieve objectives. Eligible organizations must adhere to strict submission guidelines, including a five-page narrative limit and a maximum of four one-page annexes. While a Unique Entity Identifier and SAM.gov registration are not required for the initial Statement of Interest phase, they are mandatory for any applicant moving forward to a full proposal. Awards are subject to federal regulations including 2 CFR part 200, with specific requirements for pharmaceutical quality assurance, cybersecurity in certain regions, and the maintenance of separate accounting records for different Foreign Assistance Data Review elements.

Bureau Of Global Health Security And Diplomacy

POSTED

DEADLINE

Cancer Prevention and Control Programs for State, Territorial, and Tribal OrganizationsThe Centers for Disease Control and Prevention's Division of Cancer Prevention and Control is seeking eligible state, territorial, and tribal organizations to implement comprehensive cancer surveillance, prevention, and control strategies. The primary objective is to improve health outcomes through a coordinated approach that integrates clinical preventive services and cancer survivorship to reduce the overall cancer burden in targeted communities. Funding is allocated across three national programs. The National Breast and Cervical Cancer Early Detection Program provides screening and diagnostic services for low-income women without adequate insurance, with an optional component for evidence-based interventions. The National Comprehensive Cancer Control Program supports coalition-led efforts to execute jurisdiction-wide cancer plans, while the National Program of Cancer Registries focuses on the implementation of population-based central cancer registry programs.

Centers For Disease Control - Nccdphp

POSTED

about 1 month ago

DEADLINE

Native Public Health ResilienceThe Native Public Health Resilience initiative is a forecast opportunity issued by the Indian Health Service under the Department of Health and Human Services. This program is specifically designed to provide funding to Tribes and Tribal Organizations to support the delivery of Essential Public Health Services. The opportunity is managed by the Division of Grants Management, with a posted date of September 10, 2026. Interested parties can coordinate through the provided point of contact or access further details via the official grants.gov portal.

Indian Health Service

POSTED

about 1 month ago

DEADLINE

Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)The John Lewis NIMHD Research Endowment Program, administered by the National Institutes of Health under the Department of Health and Human Services, is designed to enhance research infrastructure and training capacity at eligible institutions of higher education to support health disparities research. The program focuses on four strategic objectives: upgrading physical infrastructure and equipment, developing technical expertise, expanding relevant academic science programs, and recruiting high-level researchers for faculty positions. It is important to note that this program provides institutional support and does not directly fund specific research projects. This opportunity is a forecast for a limited competition, meaning only eligible organizations will be invited to apply. Applications will undergo a standard NIH peer-review process, and funding will be awarded based on the merit of the proposal. Clinical trials are not allowed under this specific program.

National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

Preadmission Screening and Resident Review

Solicitation # AHCA RFP 001-26/27

The State of Florida Agency for Health Care Administration issued solicitation AHCA RFP 001-26/27 to secure a vendor for the maintenance and management of the Preadmission Screening and Resident Review (PASRR) process. The selected vendor will be responsible for conducting Level II evaluations and Resident Reviews to identify individuals with Serious Mental Illness or Intellectual Disability and determine appropriate placements and services. This fixed-price, unit-cost contract has an estimated annual value of 9,773,720.00 dollars. The vendor must be fully operational within 90 days of contract execution, with a performance period including a base term and up to three renewal years. Technical evaluations are based on the vendor's ability to complete evaluations, resident reviews, and provide ongoing education and technical assistance. Financial requirements include a performance bond equal to 10 percent of the total annual contract amount and a proposal guarantee of 977,372.00 dollars. Strict compliance is required regarding HIPAA, HITECH, and NIST cybersecurity standards, with liquidated damages for screening delays and HIPAA violations. Payments are made in arrears upon the acceptance of deliverables, which include monthly, quarterly, and annual reports. Respondents must submit their proposals by October 26, 2026, via hard copy and USB flash drive, including all required certifications and a detailed budget.

Agency for Health Care Administration

POSTED

about 1 month ago

DEADLINE

in about 1 month

Building Communities of RecoveryThe Building Communities of Recovery program, administered by the Substance Abuse and Mental Health Services Administration under the Department of Health and Human Services, is designed to help organizations mobilize and connect community resources. The primary goal of this initiative is to expand access to long-term recovery support for individuals struggling with substance use disorders as well as co-occurring substance use and mental health disorders. This opportunity is currently listed as a forecast with a posted date of September 3, 2026. Interested parties can coordinate with the point of contact, Jihane Ambroise, via email at bcor@samhsa.hhs.gov or by phone at 240-276-1600 for further information regarding the program.

Substance Abuse And Mental Health Services Administration

POSTED

about 2 months ago

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)The National Institutes of Health is seeking applicants to establish Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications. These centers will provide essential resources and testing services to the biomedical community to advance the development of genome editing technologies for treating human diseases. By collaborating with NIH-funded investigators, the centers will evaluate the efficacy and safety of delivery technologies, establish editing thresholds to minimize off-target effects, and determine feasibility within various model systems. The initiative emphasizes the creation of in vivo and in vitro research models, with a specific interest in new approach methodologies and human-biology-based models to complement traditional methods. Testing Centers are expected to develop standardized assays and operating procedures to ensure scientific rigor and reproducibility. While focusing on a limited number of initial projects, these centers will build adaptable core systems designed to support a wide range of diseases and offer fee-for-service resources on a local, regional, and national scale.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs)The National Institute on Aging, under the Department of Health and Human Services, intends to publish a Notice of Funding Opportunity for the Coordinating Center of the Claude D. Pepper Older Americans Independence Centers program. This center will act as a facilitator for site interactions and translate program objectives and findings for scientific and general audiences. The selected entity must possess significant scientific expertise in geriatrics and a proven track record of coordinating complex multi-site projects. This announcement serves as a forecast to allow potential applicants time to establish collaborations before the official solicitation is released. The funding opportunity will utilize the U24 activity code. Interested investigators with expertise in aging research are encouraged to prepare for the upcoming application process.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)The National Institute on Alcohol Abuse and Alcoholism, under the Department of Health and Human Services, intends to issue a Notice of Funding Opportunity to continue the Collaborative Initiative on Fetal Alcohol Spectrum Disorders. This multidisciplinary research consortium focuses on a wide range of studies, including basic, clinical, translational, diagnostic, intervention, and prevention research aimed at addressing the lifelong physical, cognitive, and behavioral impairments caused by prenatal alcohol exposure. The program seeks to support high-priority needs such as improving early identification and diagnosis, validating interventions, and exploring the mechanisms of alcohol teratogenesis to reduce the incidence of these disorders. Successful projects must demonstrate strong integration with the broader consortium through the use of shared resources, coordinated data activities, and multidisciplinary expertise. This forecast indicates a research program where clinical trials are optional.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Centers for Research on Neglected Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is establishing the Centers for Research on Neglected Infectious Diseases to combat communicable viral, bacterial, parasitic, and fungal infections. This initiative focuses on the epidemiology, pathogenesis, diagnosis, treatment, and prevention of parasitic neglected infectious diseases within endemic regions. By building sustainable in-country research capacity and expertise, the program aims to identify, contain, and mitigate these diseases at their source to protect global health and reduce the risk of spread within the United States. This opportunity is issued as a forecast by the Department of Health and Human Services and is governed by the Public Health Service Act and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Interested parties can coordinate with the Division of Microbiology and Infectious Diseases for further information. The program emphasizes a multidisciplinary approach to research and training to address the substantial morbidity and mortality associated with understudied infectious diseases.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.

Book Publishers

POSTED

DEADLINE

Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS